Causes of Etiopathogenesis and Mortality in Lungs Cancer

Abstract

Lung cancer is a serious health concern that is associated with a poor prognosis and low survival rate. It is widely recognized as one of the most common types of cancer, particularly among individuals in their third decade of life. Given the high incidence and severity of this disease, extensive research has been conducted in an effort to improve patient outcomes.

The current study used a systematic approach to identify relevant studies, utilizing biomedical bibliographic databases as the primary sources of information. A thorough search was conducted, and 58 publications were initially identified. After a rigorous screening process, 25 of these studies were selected for further analysis.

The chosen studies represent a diverse range of research on lung cancer, including investigations into epidemiology, pathogenesis, diagnosis, and treatment. The results of these studies provide a comprehensive overview of the current state of knowledge regarding lung cancer, and highlight key areas that require further investigation.

This study underscores the need for continued research into the prevention and treatment of lung cancer, in order to improve the outcomes for patients and reduce the burden of this disease on society. The findings of this study can be used to guide future research efforts, and inform clinical practice, in order to help improve patient outcomes and reduce the impact of lung cancer.

Goals:

To describe and study certain aspects of lung cancer, focusing on its epidemiology, etiology, and lymph node staging.

Improvement:

 It was updated with new categories of tumor components (T) and metastases (M), as well as the advent of new stages, but did not change the lymph node component (N) in its eighth version, which was released in 2016; Despite this, patients with non-small cell lung cancer should consider the prognostic and therapeutic implications of the assessment of the mediastina lymph node (pN)(Lopez et al., 2022).

Conclusions:

TNM staging is crucial in determining prognosis and therapeutic decisions because non-small cell lung cancer is the most prevalent and deadly cancer globally, affecting an elderly population. Environmental, genetic, and molecular factors are thought to play a role in its development. Affection is correctly identified. The lymph node is essential since it will decide the prognosis even if there are no metastases. With the advancement of modern science, the process used to construct the various TNM editions is continually changing.